Search Results

Filter
  • 1-6 of  6 results for ""Artemether, Lumefantrine Drug Combination""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Increasing Prevalence of Artemisinin-Resistant HRP2-Negative Malaria in Eritrea.

  • Authors : Mihreteab S; From the National Malaria Control Program (S.M.) and the Communicable Diseases Control Division (A.B.), Ministry of Health, and the World Health Organization (A.Z.K.) - both in Asmara, Eritrea; the Malaria Genetic and Resistance Unit, INSERM Unité 1201 (L.P., N.P., E.L., D.M.), the Malaria Parasite Biology and Vaccines Unit (L.P., E.L. D.M.), the Bioinformatics and Biostatistics Hub (P.C., A.C.), and the Biomics Platform, Center for Technological Resources and Research (L.M.), Institut Pasteur, Université Paris Cité, and Collège Ecole Doctorale Complexité du Vivant, Sorbonne Université (L.P.), Paris, and the Institute of Parasitology and Tropical Diseases, Dynamics of Host-Pathogen Interactions, Université de Strasbourg (C.D.-L., D.M.), and the Laboratory of Parasitology and Medical Mycology, Centre Hospitalier Universitaire Strasbourg (D.M.), Strasbourg - all in France

Subjects: Antimalarials*/Antimalarials*/Antimalarials*/pharmacology ; Antimalarials*/Antimalarials*/Antimalarials*/therapeutic use ; Artemether, Lumefantrine Drug Combination*/Artemether, Lumefantrine Drug Combination*/Artemether, Lumefantrine Drug Combination*/pharmacology

  • Source: The New England journal of medicine [N Engl J Med] 2023 Sep 28; Vol. 389 (13), pp. 1191-1202.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited

Record details

×
Academic Journal

Subcutaneous Administration of a Monoclonal Antibody to Prevent Malaria.

Subjects: Malaria, Falciparum*/Malaria, Falciparum*/Malaria, Falciparum*/drug therapy ; Malaria, Falciparum*/Malaria, Falciparum*/Malaria, Falciparum*/epidemiology ; Malaria, Falciparum*/Malaria, Falciparum*/Malaria, Falciparum*/prevention & control

  • Source: The New England journal of medicine [N Engl J Med] 2024 May 02; Vol. 390 (17), pp. 1549-1559. Date of Electronic Publication: 2024 Apr 26.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model:

Record details

×
Academic Journal

Safety and Efficacy of a Monoclonal Antibody against Malaria in Mali.

Subjects: Antimalarials*/Antimalarials*/Antimalarials*/adverse effects ; Antimalarials*/Antimalarials*/Antimalarials*/therapeutic use ; Malaria, Falciparum*/Malaria, Falciparum*/Malaria, Falciparum*/diagnosis

  • Source: The New England journal of medicine [N Engl J Med] 2022 Nov 17; Vol. 387 (20), pp. 1833-1842. Date of Electronic Publication: 2022 Oct 31.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model:

Record details

×
Academic Journal

Four Artemisinin-Based Treatments in African Pregnant Women with Malaria.

Subjects: Antimalarials/Antimalarials/Antimalarials/*therapeutic use ; Artemisinins/Artemisinins/Artemisinins/*therapeutic use ; Malaria, Falciparum/Malaria, Falciparum/Malaria, Falciparum/*drug therapy

  • Source: The New England journal of medicine [N Engl J Med] 2016 Mar 10; Vol. 374 (10), pp. 913-27.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited

Record details

×
Academic Journal

Effect of Artesunate-Amodiaquine on Mortality Related to Ebola Virus Disease.

  • Authors : Gignoux E; From the Epicentre (E.G., A.T.) and Médecins sans Frontières Access Campaign (J.P.), Paris, and Laboratoire P4 Jean Merieux, INSERM, Lyon (A.B.) - all in France; Médecins sans Frontières, Geneva (E.G., A.S.A., D.J., A.T., R.P., E.S., M. Suzuki, J.-C.C., M. Serafini, I.C.)

Subjects: Amodiaquine/Amodiaquine/Amodiaquine/*therapeutic use ; Antimalarials/Antimalarials/Antimalarials/*therapeutic use ; Artemisinins/Artemisinins/Artemisinins/*therapeutic use

  • Source: The New England journal of medicine [N Engl J Med] 2016 Jan 07; Vol. 374 (1), pp. 23-32.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited

Record details

×
Academic Journal

Antiretroviral agents and prevention of malaria in HIV-infected Ugandan children.

  • Authors : Achan J; Department of Pediatrics and Child Health, Makerere University College of Health Sciences, Kampala, Uganda. ; Kakuru A

Subjects: Anti-Retroviral Agents/Anti-Retroviral Agents/Anti-Retroviral Agents/*therapeutic use ; HIV Infections/HIV Infections/HIV Infections/*drug therapy ; Lopinavir/Lopinavir/Lopinavir/*therapeutic use

  • Source: The New England journal of medicine [N Engl J Med] 2012 Nov 29; Vol. 367 (22), pp. 2110-8.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited

Record details

×
  • 1-6 of  6 results for ""Artemether, Lumefantrine Drug Combination""